Christopher Manion
Papers
1
Total Citations
5
H-Index
1
About
Christopher Manion is a pioneering researcher at the intersection of interventional cardiology, neuroprotection, and artificial intelligence. His primary research focuses on real-time cerebral emboli detection and autonomous neuromonitoring during high-risk cardiovascular procedures, particularly transcatheter aortic valve replacement (TAVR). Manion’s major contribution is the development and clinical validation of a novel robotic transcranial Doppler (TCD) system integrated with artificial intelligence, enabling continuous, hands-free intraoperative monitoring of microembolic signals. In his landmark 2023 pilot study, he demonstrated the feasibility of this AI-driven platform to detect cerebral emboli with unprecedented precision, both with and without embolic protection devices. This work has profound implications for reducing periprocedural ischemic stroke—a devastating complication in TAVR—by providing real-time feedback to clinicians. Though early in its citation impact (5 citations), this study represents a foundational advance in automated neurocritical care. Manion’s research bridges engineering, neurology, and cardiac surgery, positioning him as a key innovator in smart, AI-assisted procedural safety. His work promises to transform how we monitor and protect the brain during invasive cardiovascular interventions.
Research Focus
Key Achievements
Top Papers
- 1